Companies › Eli Lilly › Stockholders' equity
Eli Lilly stockholders' equity, 2008–2025
Eli Lilly reported stockholders' equity of $26.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 85.9% from $14.3 billion the year before, according to its Form 10-K.
Fiscal years labeled by the year in which they ended. Bars drawn from the table below.
Eli Lilly stockholders' equity by fiscal year
| Fiscal year ended | Stockholders' equity | Change | Filing |
|---|---|---|---|
| Dec. 31, 2025 | $26.5B | +85.9% | 10-K (2026) ↗ |
| Dec. 31, 2024 | $14.3B | +32.5% | 10-K (2026) ↗ |
| Dec. 31, 2023 | $10.8B | +1.1% | 10-K (2025) ↗ |
| Dec. 31, 2022 | $10.6B | +18.6% | 10-K (2024) ↗ |
| Dec. 31, 2021 | $8.98B | +59.2% | 10-K (2023) ↗ |
| Dec. 31, 2020 | $5.64B | +116.4% | 10-K (2022) ↗ |
| Dec. 31, 2019 | $2.61B | −73.5% | 10-K (2021) ↗ |
| Dec. 31, 2018 | $9.83B | −15.2% | 10-K (2020) ↗ |
| Dec. 31, 2017 | $11.6B | −17.2% | 10-K (2019) ↗ |
| Dec. 31, 2016 | $14.0B | −3.9% | 10-K (2018) ↗ |
| Dec. 31, 2015 | $14.6B | −5.2% | 10-K (2018) ↗ |
| Dec. 31, 2014 | $15.4B | −12.8% | 10-K (2018) ↗ |
| Dec. 31, 2013 | $17.6B | +19.4% | 10-K (2017) ↗ |
| Dec. 31, 2012 | $14.8B | +9.0% | 10-K (2016) ↗ |
| Dec. 31, 2011 | $13.5B | +9.0% | 10-K (2015) ↗ |
| Dec. 31, 2010 | $12.4B | +30.4% | 10-K (2014) ↗ |
| Dec. 31, 2009 | $9.53B | +41.4% | 10-K (2011) ↗ |
| Dec. 31, 2008 | $6.74B | — | 10-K (2010) ↗ |
Other Eli Lilly financials
RevenueNet incomeDiluted EPSR&D expenseOperating cash flowDividends per shareDiluted sharesTotal assetsCash and equivalents Quarterly results and next earnings date Eli Lilly company hub
FAQ
Q What was Eli Lilly's stockholders' equity in its latest fiscal year?
A Eli Lilly reported stockholders' equity of $26.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 85.9% from $14.3 billion the year before, according to its Form 10-K.
Q What is Eli Lilly's highest annual stockholders' equity on record here?
A $26.5 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.
Q Where does this stockholders' equity data come from?
A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Total stockholders' equity on the balance sheet at fiscal year-end.
Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Total stockholders' equity on the balance sheet at fiscal year-end. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.